Infants receiving nirsevimab fare better against RSV compared to those with maternal vaccination

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and children, it causes only mild, cold-like symptoms and goes away on its own. Infants under 6 months of age, however, can become much sicker and might need special medical care. It is one of the leading reasons for infants getting hospitalized.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup